[HTML][HTML] STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

JJ Qin, L Yan, J Zhang, WD Zhang - Journal of Experimental & Clinical …, 2019 - Springer
Triple negative breast cancer (TNBC), which is typically lack of expression of estrogen
receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 …

Immune checkpoints in the tumor microenvironment

SM Toor, VS Nair, J Decock, E Elkord - Seminars in cancer biology, 2020 - Elsevier
Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell
activation pathways involved in physiological immune responses against specific antigens …

STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges

GL Wong, SG Manore, DL Doheny, HW Lo - Seminars in cancer biology, 2022 - Elsevier
Breast cancer is the most commonly diagnosed cancer and second-leading cause of cancer
deaths in women. Breast cancer stem cells (BCSCs) promote metastasis and therapeutic …

Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression

L Peng, B Pan, X Zhang, Z Wang, J Qiu, X Wang… - Cell biology and …, 2022 - Springer
Recent studies have suggested that the initiation and progression of hepatocellular
carcinoma (HCC) are closely associated with lipopolysaccharide (LPS) of intestinal bacteria …

[HTML][HTML] NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma

F Lu, Y Zhao, Y Pang, M Ji, Y Sun, H Wang, J Zou… - Cancer letters, 2021 - Elsevier
The NLRP3 inflammasome plays a pro-tumorigenic role in various malignancies. However,
its potential role in lymphomagenesis remains unclear. In this study, we identified an …

[HTML][HTML] Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways

N Chuangchot, P Jamjuntra, S Yangngam… - Breast Cancer …, 2023 - Springer
Abstract Background Carcinoma-associated fibroblasts (CAFs) play a critical role in cancer
progression and immune cell modulation. In this study, it was aimed to evaluate the roles of …

Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy

BA Kiasari, A Abbasi, NG Darestani, N Adabi… - International …, 2022 - Elsevier
Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1 or CD279)
have noticeably improved the treatment landscape of advanced cancer patients. Nivolumab …

[HTML][HTML] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells

R Saleh, SM Toor, S Khalaf, E Elkord - Vaccines, 2019 - mdpi.com
Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype, and it
exhibits resistance to common breast cancer therapies. Immune checkpoint inhibitors (ICIs) …

[HTML][HTML] STAT3 signaling in breast cancer: multicellular actions and therapeutic potential

SQ To, RS Dmello, AK Richards, M Ernst, AL Chand - Cancers, 2022 - mdpi.com
Simple Summary Many signaling pathways are overactive in breast cancer, and among
them is the STAT3 signaling pathway. STAT3 is activated by secreted factors within the …

[HTML][HTML] STAT3 activity promotes programmed-death ligand 1 expression and suppresses immune responses in breast cancer

I Zerdes, M Wallerius, EG Sifakis, T Wallmann, S Betts… - Cancers, 2019 - mdpi.com
Signal transducer and activator of transcription 3 (STAT3) is an oncogene and multifaceted
transcription factor involved in multiple cellular functions. Its role in modifying anti-tumor …